Ipratropium (Atrovent, Atrovent HFA)
Anesthesia Implications
Clinically reviewed by anesthesia providers · Updated
Classification:
Quaternary anticholinergic, muscarinic receptor antagonist, inhaled bronchodilator
Therapeutic Effects:
Bronchodilation, reduction of airway mucus secretion